Print
Email
Myriad Genetics Inc. has a market cap of $2.03 billion; its shares were traded at around $24 with a P/E ratio of 19.5 and P/S ratio of 5.
This is the insider trade history vs. stock price of MYGN. For the complete insider trading history of MYGN, click here.
Directors and Officers Recent Trades:
- Chief Scientific Officer Jerry S Lanchbury sold 21,804 shares of MYGN stock on 02/01/2012 at the average price of 24.05. Jerry S Lanchbury owns at least 22,735 shares after this. The price of the stock has decreased by 0.21% since.
- President & C.E.O. Peter D Meldrum sold 30,200 shares of MYGN stock on 02/01/2012 at the average price of 23.95. Peter D Meldrum owns at least 180,921 shares after this. The price of the stock has increased by 0.21% since.
- President & C.E.O. Peter D Meldrum sold 15,000 shares of MYGN stock on 01/26/2012 at the average price of 23.04. Peter D Meldrum owns at least 180,921 shares after this. The price of the stock has increased by 4.17% since.
For the complete insider trading history of MYGN, click here.
Subscribe RSS
